洛伐他汀对接受环孢素免疫抑制治疗的肾移植受者高脂血症的治疗作用 - Suppr | 超能文献

Lovastatin treatment of hyperlipidemia in kidney transplant recipients on cyclosporine immunosuppression.

作者信息

Kandus A, Kovac D, Koselj M, Kveder R, Bren A F

机构信息

Department of Nephrology, University Medical Centre, Ljubljana, Slovenia.

出版信息

Transplant Proc. 1994 Oct;26(5):2642-3.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Lovastatin treatment of hyperlipidemia in kidney transplant recipients on cyclosporine immunosuppression.洛伐他汀对接受环孢素免疫抑制治疗的肾移植受者高脂血症的治疗作用

Transplant Proc. 1994 Oct;26(5):2642-3.

2

Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A.环孢素A治疗的高脂血症肾移植受者服用低剂量洛伐他汀。

Transplant Proc. 1992 Dec;24(6):2745-7.

3

Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.普伐他汀与洛伐他汀在接受环孢素治疗的肾移植患者中的比较。

Transplant Proc. 1996 Dec;28(6):3126-8.

4

Effect of lovastatin and bezafibrate on cyclosporine-induced hyperlipidemia in rabbits.洛伐他汀和苯扎贝特对环孢素诱导的兔高脂血症的影响。

Transplant Proc. 1995 Apr;27(2):1857-61.

5

Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.普伐他汀对接受环孢素治疗的肾移植受者的影响——4年随访

Transplant Proc. 1994 Oct;26(5):2632-3.

6

Dislipidemia at different immunosuppressive protocols.不同免疫抑制方案下的血脂异常

Transplant Proc. 1994 Dec;26(6):3223.

7

Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.

Transplant Proc. 1995 Aug;27(4):2222-3.

8

Impact of fluvastatin on hyperlipidemia after renal transplantation.氟伐他汀对肾移植术后高脂血症的影响。

Transplant Proc. 2004 Sep;36(7):2141-4. doi: 10.1016/j.transproceed.2004.06.027.

9

Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine A immunosuppression: three-year experience.肾移植患者接受环孢素A免疫抑制治疗时使用洛伐他汀治疗高脂血症：三年经验

Transplant Proc. 1998 Jun;30(4):1307-9. doi: 10.1016/s0041-1345(98)00253-x.

10

Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).

Transplant Proc. 1994 Oct;26(5):2637-8.

引用本文的文献

1

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.HMG-CoA还原酶抑制剂的药代动力学-药效学药物相互作用

Clin Pharmacokinet. 2002;41(5):343-70. doi: 10.2165/00003088-200241050-00003.